Home > Insider Trading > Filing (0001209191-14-058900)

Filing Details

Accession Number:: 0001209191-14-058900
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-09-19 19:22:32
Reporting Period:: 2014-09-17

Filing Date:: 2014-09-19
Accepted Time:: 2014-09-19 19:22:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1479290	Revance Therapeutics Inc.	RVNC	Pharmaceutical Preparations (2834)	770551645

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1597580	Jacob Waugh	C/O Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark CA 94560	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-09-17	1,666	$6.60	54,999	No	4	M	Direct
Common Stock	Acquisiton	2014-09-17	5,000	$2.55	59,999	No	4	M	Direct
Common Stock	Acquisiton	2014-09-17	5,666	$2.55	65,665	No	4	M	Direct
Common Stock	Acquisiton	2014-09-17	48,437	$8.70	114,102	No	4	M	Direct
Common Stock	Acquisiton	2014-09-17	8,611	$9.15	122,713	No	4	M	Direct
Common Stock	Disposition	2014-09-17	8,611	$21.50	114,102	No	4	S	Direct
Common Stock	Disposition	2014-09-17	44,137	$20.60	69,965	No	4	S	Direct
Common Stock	Disposition	2014-09-17	4,300	$21.28	65,665	No	4	S	Direct
Common Stock	Disposition	2014-09-17	11,632	$20.62	54,033	No	4	S	Direct
Common Stock	Disposition	2014-09-17	700	$21.26	53,333	No	4	S	Direct
Common Stock	Disposition	2014-09-17	25,833	$20.58	27,500	No	4	S	Direct
Common Stock	Disposition	2014-09-17	2,500	$21.27	25,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-17	1,666	$0.00	1,666	$6.60
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-17	5,000	$0.00	5,000	$2.55
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-17	5,666	$0.00	5,666	$2.55
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-17	48,437	$0.00	48,437	$8.70
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-17	8,611	$0.00	8,611	$9.15

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-06-18	No	4	M	Direct
0	2018-04-29	No	4	M	Direct
0	2020-07-20	No	4	M	Direct
106,563	2023-05-26	No	4	M	Direct
43,055	2023-12-16	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.12 to $21.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.13 to $21.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.14 to $21.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.15 to $21.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.13 to $21.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.15 to $21.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The Option is fully vested as of July 19, 2011.
The Option is fully vested as of January 1, 2012.
The Option is fully vested as of January 1, 2014.
The Option shares shall vest as follows: 1/48th of the total number of shares subject to the Option shall vest in 48 equal monthly installments over 4 years following May 27, 2013, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan) as of such date.
The Option shares shall vest as follows: 1/48th of the total number of shares subject to the Option shall vest in 48 equal monthly installments over 4 years following December 17, 2013, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan) as of such date.